Poseltinib (HM71224, LY3337641)
目录号: A19450
BTK 抑制剂
Poseltinib 是一种口服活性、选择性和不可逆的 Bruton's tyrosine kinase (BTK) 抑制剂(IC50 = 1.95 nM),对 BTK 的选择性分别是 BMX、TEC 和 TXK 的 0.3、2.3 和 2.4 倍。
Discription | Poseltinib, an orally active, selective and irreversible Bruton??s tyrosine kinase (BTK) inhibitor (IC50 =1.95 nM), with 0.3, 2.3 and 2.4-fold selectivity for BTK over BMX, TEC and TXK, respectively. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A19450 |
---|---|
分子式 | C26H26N6O3 |
分子量 | 470.52 |
CAS号 | 1353552-97-2 |
SMILES | O=C(C=C)NC1=CC=CC(OC2=C(OC=C3)C3=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=N2)=C1 |
其他名称 | HM 71224, HM-71224, LY-333764, LY 33376411 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2